Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
3.910
+0.340 (9.52%)
At close: Nov 13, 2026, 4:00 PM EST
3.920
+0.010 (0.26%)
After-hours: Nov 13, 2026, 7:59 PM EST
Aquestive Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $10 | Buy | Reiterates | $10 | +155.75% | Nov 9, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $11 | Buy | Reiterates | $11 | +181.33% | Nov 5, 2026 |
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Maintains $9 | Buy | Maintains | $9 | +130.18% | Nov 5, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +155.75% | Sep 17, 2026 |
| Lake Street | Lake Street | Buy Maintains $6 | Buy | Maintains | $6 | +53.45% | Sep 17, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 | Buy | Maintains | $11 | +181.33% | Jun 26, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +104.60% | Jun 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $8 | Buy | Reiterates | $8 | +104.60% | May 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.